News Story: Full Text
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

 

Musella Foundation awards 7 brain tumor research grants!

Al's Comment:

 I would like to thanks all of the volunteers and participants in our "Natioanl Walk To End Brain Tumors" who made this possible, as well as the donors to our organization and the families that named us for memorial donations.


Posted on: 06/01/2017

Musella Foundation awards 7 brain tumor research grants!

 
Hewlett, NY 6/1/2017 - The Musella Foundation announced that it has awarded $205,000  in 7 brain tumor research grants.  These funds come from our “National Walk To End Brain Tumors” 5k events and donations to our organization.  We thank the many volunteers and donors that made this possible. Hopefully, these projects will quickly make a meaningful difference in the fight against brain tumors!
 
These grants include:
 
  • $25,000 to Dr.Joshua Allen at Oncoceutics for project "Clinical Evaluation of DRD5 as a Predictive Biomarker of Response to the selective DRD2 antagonist ONC201". This project will look for biomarkers to try to predict which patients would be helped by their new drug, ONC201.
     
  • $5,000 to the Central Brain Tumor Registry of the USA to enable them to compile statistics on brain tumors.
     
  • $25,000 to Dr. Neadu at Dana Farber Cancer Institute, for the project "Defining molecular mechanisms of resistance to Glioblastoma (GBM) immunity using a novel CRISPR/Cas9 in vivo loss-of-function screening platform". This is a completely new way to screen for the genes involved.
     
  • $25,000 to Dr Okada, at UCSF, for the project: "Targeting the glioma immune environment by creating tertiary lymphoid organs", completely new concept of creating new lymphoid organs in the brain to enhance the immune response.
     
  • $50,000 to Dr. Renfrow, at Wake Forest University, for the project "Targeting Hypoxia Inducible Factors in Gliomas". This will test a drug approved for kidney cancer in a mouse model to Glioblastoma. If successful, it will quickly lead to a clinical trial and since it is already approved, can help patients in the very near future.
     
  • $50,000 to Dr Schwartz at Hackensack University Hospital, for the project "Potentiating radiation therapy of GBM with telmisartan and immune checkpoint inhibitors". This project will test the combinations of 2 checkpoint inhibitors and telmisartan, along with radiation, in a mouse model of glioblastoma. All of these drugs are approved for other diseases so if successful, can quickly lead to a clinical trial and become quickly available.
     
  • $25,000 to Dr Srendi at Ann and Robert H. Lurie Children's Hospital of Chicago for the project "Qualification of the PLK4 inhibitor CFI-400945 for future clinical trials on pediatric brain tumors: moving from the bench to the bedside". This project will test an experimental drug that is being developed for other cancers to see if it could work on pediatric brain tumor patients, with an emphasis on atypical teratoid/rhabdoid (AR/RT) tumors.
 
This brings the total number of brain tumor research grant funded by the Musella Foundation to 102! 
 
Unfortunately, we had to reject some very worthwhile projects because we did not have enough money.  If any organization (or individual) would like to sponsor one of the other projects that our grants committee already approved, please contact us!
 
About the Musella Foundation
 
 
The Musella Foundation For Brain Tumor Research & Information, Inc is a 501(c)3 non- profit organization dedicated to speeding up the search for the cure of brain tumors, as well as helping families deal with the diagnosis of brain cancer, by funding innovative brain tumor research, education, advocacy, emotional and financial support for families that are dealing with brain tumors and organizing the brain tumor community to work together as an army to fight the disease. 
 
The “Clinical Trials and Noteworthy Treatments For Brain Tumors” website at http://virtualtrials.com, the “Brain Tumor Copayment Assistance Program”  website at http:// braintumorcopays.org, “The National Walk To End Brain Tumors” website at http://walktoendbraintumors.org and the “Grey Ribbon Crusade”  website at http://greyribboncrusade.org/ are all maintained by the Musella Foundation For Brain Tumor Research & Information, Inc.
 
Contact: Al Musella, DPM
President Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740
musella@virtualtrials.com
 
 

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites



Musella Foundation For Brain Tumor Research & Information, Inc